Go to content

Evaluating facility-level variability in urinary antimicrobial susceptibility patterns in long-term care homes in Ontario, Canada

Share

Antimicrobial resistance surveillance in long-term care homes is limited by its reliance on organism-specific summaries, most commonly Escherichia coli, which may not reflect the broader microbiological landscape in these settings. We evaluated how E. coli-based urinary susceptibility compared with weighted-incidence syndromic combination antibiograms (WISCA), a composite measure incorporating multiple pathogens, across 627 Ontario long-term care homes in 2023. Facility-level antimicrobial susceptibilities to eight antibiotics were estimated using 23,750 urinary isolates, with missing data addressed through imputation, and estimates stabilized using random-intercept logistic regression models. E. coli accounted for a mean of 50.6% (standard deviation = 1.9) of urinary isolates, with the remaining 49.5% mainly comprising Klebsiella pneumoniae (16.6% [0.8]), Proteus mirabilis (11.9% [1.2]), Enterococcus faecalis (6.6% [2.1]), and Pseudomonas aeruginosa (6.1% [0.1]). Organism-specific susceptibility varied substantially across antibiotics, particularly for ciprofloxacin susceptibility in P. mirabilis (78.7% [13.1]) and E. faecalis (48.9% [11.5]), and nitrofurantoin susceptibility in K. pneumoniae (48.5% [9.0]). Compared with E. coli-based estimates, WISCA susceptibilities were lower for seven of eight antibiotics, most notably for nitrofurantoin (WISCA: 70.6% vs E. coli: 96.8%). These findings suggest that reliance on E. coli alone may not fully capture facility-level urinary susceptibility patterns, as variation in pathogen distribution and organism-specific antibiotic susceptibilities across homes can produce substantially different susceptibility estimates. WISCA provides a more representative and stable measure by incorporating pathogen diversity and weighting organism prevalence. Integrating this into antimicrobial resistance surveillance for long-term care homes may improve the detection of emerging resistance trends and better inform antimicrobial stewardship strategies by identifying variable organism-antibiotic combinations.

Information

Citation

Wong MK, Daneman N, Langford BJ, Leung V, Schwartz KL, Swayze S, Amer A, Braukmann T, MacFadden DR, Brown KA. J Clin Microbiol. 2026; Nov 11 [Epub ahead of print].

View Source

Associated Sites